Design and development of mesoporous glass-based biomaterials for bone tissue engineering and drug release systems
Year: 2016
Type: dissertation
Abstract: In order to overcome clinical challenges for bone tissue regeneration, current tissue engineering research focuses on developing highly performant biomaterials in terms of multifunctionality, i.e. materials that are capable of stimulating bone regeneration and exhibit drug delivery capabilities as well as sufficient mechanical stability. In the framework of this research topic, the work here presented focuses on the development of multifunctional mesoporous bioactive glasses (mBGs) and on the fabrication of mechanically competent 3D scaffolds from such mBGs. In a first step, three main compositions of mesoporous bioactive glasses, based on the sol-gel process in combination with the supramolecular chemistry of surfactants, were developed: (in mol%) 60%SiO2 30%CaO 5%P2O5 5%Na2O (MBG); 78%SiO2 20%CaO 1.2%P2O5 0.4%SrO 0.4%CuO (C) and 78%SiO2 20%CaO 1.2%P2O5 0.8%CoO (D). Two of these compositions incorporated known osteogenic and angiogenic metallic ions (Sr2+ and Cu2+ on the one hand and Co2+ on the other hand), whose aim was to increase the biological activity of the glasses. Highly ordered mesoporosity was achieved for compositions C and D, mainly confirmed by TEM and SAXRD. Their specific surface area was evaluated by BET and it was 254 m2/g for composition C and 346 m2/g for composition D, with average pore size of 3 nm and 3.6 nm respectively. However, a disordered mesoporous structure was observed for composition MBG and the specific surface area only reached 150 m2/g with average pore size of 7 nm. These new compositions exhibited fast bioactive behaviour in simulated body fluid by developing in their surface an apatite-like layer in less than 24 hours, characterised by FTIR spectroscopy and SEM analysis. The drug uptake and release capabilities of these compositions were tested and measured by UV-Vis for different active molecules (tetracycline, ibuprofen and resveratrol), in comparison to the base sol-gel composition SG (specific surface area by BET: 66 m²/g) and the well-known MCM-41 (specific surface area by BET: 1159 m²/g). In addition, indirect cell tests, performed with ST-2 cell line, revealed no cytotoxic effects after 24 h incubation. Furthermore, VEGF release over 24 hours was measured and it was found that VEGF release was enhanced in the presence of therapeutic ions (Sr2+, Cu2+ and Co2+). In a second step, highly porous (>90% porosity) 3D scaffolds with interconnected porosity were successfully produced by 3 variations of the foam replica technique (direct sol-gel, slurry and by electrophoretic deposition) and 3D printing. In order to increase the scaffolds compressive strength, a polymer infiltration approach was used. The compression strength of scaffolds was significantly increased, from 0.02 to 2.6 MPa, by applying a gelatin coating, without compromising the open and interconnected porosity of the scaffolds. Results obtained in this thesis suggest that mainly compositions C and D are promising mesoporous bioactive glasses to produce multifunctional biomaterials for bone regeneration applications, as they present synergistic effects by the release of both active molecules and therapeutic ions while being able to be processed as powders and 3D scaffolds.
Author: Anahí Philippart
Language: English
Subfield: Biomedical Engineering
Field: Engineering
Domain: Physical Sciences
Open Access status: green
OpenAlex ID: W3194209105
